Silicon Valley executives have begun describing smoking as a symbolic gesture of confidence in artificial intelligence, according to statements made during a CBS interview. Palantir chief technology officer Shyam Sankar told CBS News' Margaret Brennan that some AI researchers have taken up smoking to signal their belief that AI systems will eventually solve major health challenges, including cancer. Sankar described this behavior as a 'bet' that AI breakthroughs will arrive imminently, comparing it to placing 'chips on the table' to demonstrate commitment to the technology.

The remarks came during a discussion about effective altruism, a philosophical approach emphasizing long-term, data-driven decisions to maximize societal benefit. Sankar characterized certain interpretations of effective altruism as fostering 'millenarian doomsday cult' mindsets among AI developers, particularly those expressing extreme optimism about artificial general intelligence. He suggested that some proponents fill a 'god-shaped hole' in their worldview with faith in AI's eventual ability to 'cure cancer' or other ailments.

Sankar referred to the practice as 'mass psychosis' and 'social delusion,' arguing it distracts from substantive technical discourse about AI capabilities and limitations. He noted that only about 2,000 AI researchers operate in the United States, with most adhering to effective altruist principles that prioritize long-term existential risks over immediate practical concerns.

A cancer researcher who spoke with The Register expressed skepticism about the smoking symbolism, stating that developing new cancer treatments typically requires years of research and testing, regardless of AI advancements. The researcher emphasized that AI's role in drug discovery remains largely experimental, with no proven timeline for delivering breakthrough therapies. They also highlighted the health risks of smoking, noting that non-smoking associates and family members would inevitably face exposure to secondhand smoke.

The comments reflect a broader tension between technological optimism and practical risk assessment in the AI industry. While some leaders frame extreme beliefs as necessary bets on AI's future, experts caution that such narratives may obscure realistic timelines for medical innovation and overlook established health hazards associated with smoking.